Sixera Pharma AB is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2012, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas av Hansson, Stig Lennart i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva verksamhet bestående i forskning, utveckling och kommersialisering av läkemedel samt därmed förenlig verksamhet.
In its most recent annual report (2024), Sixera Pharma AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 7.2m.
At the end of 2024, equity financed 61.5% of the balance sheet, and current assets covered short-term debt 3.2 times.
Frequently asked questions
What is the Org number of Sixera Pharma AB?
Sixera Pharma AB is registered with Bolagsverket / SCB under Org 5569014763.
Who is the CEO of Sixera Pharma AB?
Maarten De Chateau is the CEO of Sixera Pharma AB, in role since 2020.
Who is the chairman of Sixera Pharma AB?
Stig Lennart Hansson chairs the board of Sixera Pharma AB, in role since 2020.
Where is Sixera Pharma AB headquartered?
Sixera Pharma AB's registered address is Skeppsbron 16.
